Rating History for Amneal Pharmaceuticals (AMRX) by UBS

More Stocks Rated by UBS | Latest Ratings for AMRX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
4/17/2026 Ashwani Verma New Coverage Buy
(N/A)		 19.00
(N/A)		 13.05
(16.21)		 24.21% Details